Why the study?
Sevoflurane is reputed to protect against myocardial ischemia-reperfusion injury, but existing evidence remains inconclusive.
Does sevoflurane (administered as pretreatment, preconditioning, or postconditioning) improve cardiac function and reduce myocardial infarct size in rat and mouse models of myocardial ischemia-reperfusion injury?
Does sevoflurane (administered as pretreatment, preconditioning, or postconditioning) improve cardiac function and reduce myocardial infarct size in rat and mouse models of myocardial ischemia-reperfusion injury?
This preclinical meta-analysis demonstrates that sevoflurane pretreatment, preconditioning, and postconditioning significantly improve cardiac function and reduce myocardial infarct size, apoptosis, and oxidative stress in rodent models of myocardial ischemia-reperfusion injury.
Answers are grounded in this paper and cite their sources.
Sevoflurane preconditioning reduces infarct size in animal I/R models; supports clinical translation trials but should not yet alter practice.
BACKGROUND: Myocardial ischemia-reperfusion (I/R) injury significantly impacts recovery in both cardiac and noncardiac surgeries, potentially leading to severe cardiac dysfunction. Sevoflurane, a volatile anesthetic, is reputed for its protective effects against myocardial I/R injury, although evidence remains inconclusive. This systematic review and meta-analysis aim to clarify the cardioprotective efficacy of sevoflurane. METHODS: The systematic search of databases including Medline, Embase, Scopus, and Web of Science, was supplemented with a manual search to retrieve studies using rat or mouse models of myocardial I/R injury, comparing sevoflurane pretreatment (≥24 h before I/R), preconditioning (within 24 h before I/R), or postconditioning (after I/R) against nontreated controls. The outcomes were cardiac function, myocardial infarct size, apoptosis, inflammation, oxidative stress, and cardiac biomarkers. Using the random effects model, standardized mean differences (SMD) were pooled to perform meta-analyses. RESULTS: Fifty-one studies, encompassing 8189 subjects, were included in the meta-analysis. Pretreatment with Sevoflurane significantly reduced infarct size. Sevoflurane preconditioning exhibited positive effects on left ventricular parameters and ejection fraction, and reduced infarct size, apoptosis, and oxidative stress. Postconditioning with Sevoflurane demonstrated improvements in cardiac function, including enhanced left ventricular parameters and reduced infarct size, apoptosis, inflammation, oxidative stress, and cardiac biomarkers. CONCLUSION: Sevoflurane demonstrates a significant protective effect against myocardial I/R injury in animal models. These findings support the potential clinical utility of sevoflurane as an anesthetic choice in preventing and managing myocardial I/R injury during surgeries.
No takes yet. Share an insight, caveat, or question.
Nasiri-Valikboni et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: